All Roll Calls
Yes: 366 • No: 57
HR2483119th CongressWALLET
SUPPORT for Patients and Communities Reauthorization Act of 2025
Sponsored By: Representative Guthrie, Brett [R-KY-2]
Became Law
Summary
Expanded federal funding for prevention, treatment, and recovery aims to lower overdoses and strengthen public health surveillance, clinical capacity, and recovery supports across communities, Tribal governments, and schools. The law funds monitoring, prevention, workforce training, and youth and family services to detect and respond to changing drug threats and support people in recovery.
Show full summary
- Prevention and surveillance: Funds prenatal and postnatal health ($4.3 million per year) and broad overdose monitoring and response activities including wastewater surveillance where permissible ($505.6 million per year). It also creates a new Fetal Alcohol Spectrum Disorders program with education, screening, and research funding ($12.5 million per year).
- Treatment and workforce: Expands residential treatment outreach for pregnant and postpartum people and boosts provider capacity and training. It raises annual workforce supports including loan repayment to $40.0 million and residential treatment funding to $38.9 million.
- Recovery, youth, and Tribal supports: Increases recovery community grants and peer-support technical assistance ($17.0 million and $2.0 million per year respectively) and phases youth prevention grants from $10.0 million to $15.0 million across FY2026–FY2030.
*Authorizes and increases annual federal appropriations across many programs for FY2026–2030, raising federal spending.*
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
10 provisions identified: 10 benefits, 0 costs, 0 mixed.
More overdose prevention and tools
The law expands overdose prevention to cover all substances causing overdoses. It provides about $505.6 million each year for 2026–2030 to track trends and respond, including wastewater checks that follow privacy laws. First responder training now covers all overdoses and more products, with $57 million each year for 2026–2030. HHS must update grant rules within one year to include any FDA‑approved or authorized overdose reversal drugs. Grants can help people access test strips (like fentanyl or xylazine) where purchase and possession are legal. HHS must also publish guidance within one year for safe at‑home drug disposal. Infection monitoring and education linked to illicit drug use stays authorized for 2026–2030.
Federal team on fentanyl risks
The law creates a federal work group on fentanyl contamination in illegal drugs. It brings agencies together, consults experts and families, and coordinates youth education and public awareness. It sends an annual report to HHS and Congress. The committee ends on September 30, 2030.
Protecting 9-8-8 from cyber threats
The law requires stronger cybersecurity for the 9-8-8 suicide and crisis lifeline. Network administrators that get federal funds must report vulnerabilities and incidents to the Assistant Secretary, and local centers must report to the network administrator. Reporting must protect personal privacy and follow federal and state privacy laws. The Comptroller General must study 9-8-8 cybersecurity risks and report within 180 days.
Better data, tech, and grants access
The National Coordinator for Health IT must hold a public roundtable within 180 days on expanding EHR use for mental health and substance use care and report recommendations. States keep choice of PDMP vendors and connections; HHS can require alignment with open standards. HHS must hold a public meeting within one year to improve access to SAMHSA grants, upgrade Grants.gov features for those grants, and report on changes. Agencies extend planning horizons to 2030 for related policy work. HHS must review how states use block grant funds for first‑episode psychosis within one year, report to Congress, and update guidance.
Easier access to clinic-given meds
Pharmacies can now deliver certain Schedule III–V drugs to the prescriber for injection or implantation for maintenance or detox treatment. For drugs with extra REMS safety rules, delivery is allowed only when those rules include post‑treatment monitoring. Within one year, FDA must publish a plan to assess approved opioid pain drugs, including timelines and steps to support nonaddictive options. HHS must review the scheduling of FDA‑approved buprenorphine/naloxone products and, if appropriate under the law, request DEA rulemaking.
More help for moms and babies
The law boosts residential treatment for pregnant and postpartum women to $38.931 million each year for 2026–2030. Applicants must include a program plan and can target outreach to women hit hardest by maternal substance use disorder. Prenatal and postnatal health programs get $4.25 million each year for 2026–2030. A new national FASD program supports education, screening, and services with $12.5 million each year for 2026–2030 and requires reporting starting within four years.
More support for youth and trauma
The child traumatic stress program is reorganized and funded at about $98.9 million each year for 2026–2028 and $100 million for 2029–2030. Grantees must create trainings, evaluate results, and work together. Trauma monitoring gets $9 million each year for 2026–2030. The trauma task force adds the Administration for Community Living, includes disability service providers, and runs through 2030. Youth prevention and recovery grants expand to secondary schools with phased funding from $10 million in 2026 to $15 million in 2030, and applicants must plan to sustain activities.
Stronger community recovery and peer help
Recovery community grants rise to $17 million each year for 2026–2030. The peer support technical assistance center gets $2 million each year for 2026–2030, may set up one regional center, must report in four years, and that authority ends September 30, 2030. Recovery centers must include documentation in applications and report on referral or contract arrangements they rely on. The law also adds diagnosis and names addiction medicine as a covered specialty, which can help people access recognized services.
More training and loan help for providers
Loan repayment funding for the substance use disorder treatment workforce rises to $40 million each year for 2026–2030. Mental and behavioral health training grants are authorized for 2026–2030. More medical and pharmacy organizations can provide or approve required prescriber training, effective December 29, 2022. The law also removes a specific old subsection on SUD record training.
Jobs and housing support in recovery
The CAREER Act program updates its formulas using 2018–2022 data. Grantees can use up to 5% of funds for transportation to work, school, training, or treatment tied to recovery. Reports must include employment and earnings outcomes, with deadlines through September 30, 2030. Funding is $12 million each year for 2026–2030, and the recovery housing pilot is reauthorized and updated.
Sponsors & CoSponsors
Sponsor
Guthrie, Brett [R-KY-2]
KY • R
Cosponsors
Rep. Pettersen, Brittany [D-CO-7]
CO • D
Sponsored 3/31/2025
Roll Call Votes
house vote • 6/4/2025
On Passage
Yes: 366 • No: 57